RecruitingPhase 4NCT06675851
Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People
Studying Mal de débarquement
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical University of Vienna
- Intervention
- WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline(drug)
- Enrollment
- 120 target
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2022 – 2026
Study locations (1)
- Medical University of Vienna, Vienna, Austria
Collaborators
Austrian Science Fund (FWF)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06675851 on ClinicalTrials.govOther trials for Mal de débarquement
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07579078Effect of Vitamin D Supplementation on Brain Waves in Female Major Depressive Disorder Patients With Hypovitaminosis DBangladesh Medical University
- RECRUITINGNCT07377682Real-world Clinical Response to Trazodone in Italy, Poland, and RomaniaAziende Chimiche Riunite Angelini Francesco S.p.A
- ACTIVE NOT RECRUITINGPHASE2NCT07458022MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDERUniversity of Child Health Sciences and Children's Hospital, Lahore
- RECRUITINGNCT07422844Dynamic Network Response to TMS TreatmentGoethe University
- RECRUITINGNANCT07316803Group Intervention for Romantic Relationships in Young Adults With Severe Mental IllnessCentre hospitalier de Ville-Evrard, France
- RECRUITINGNCT07258485A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)Janssen Research & Development, LLC
- RECRUITINGNANCT07009223Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical PracticeIRCCS Centro San Giovanni di Dio Fatebenefratelli
- RECRUITINGPHASE4NCT07136714Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or ObesityNordsjaellands Hospital